The authors report they have no financial relationships within the past 3 years to disclose.
A preliminary investigation of the effects of cognitive behavioral therapy for panic disorder on gastrointestinal distress in patients with comorbid panic disorder and irritable bowel syndrome†
Article first published online: 18 JUL 2011
© 2011 Wiley Periodicals, Inc.
Depression and Anxiety
Volume 28, Issue 11, pages 1027–1033, November 2011
How to Cite
Gros, D. F., Antony, M. M., McCabe, R. E. and Lydiard, R. B. (2011), A preliminary investigation of the effects of cognitive behavioral therapy for panic disorder on gastrointestinal distress in patients with comorbid panic disorder and irritable bowel syndrome. Depress. Anxiety, 28: 1027–1033. doi: 10.1002/da.20863
- Issue published online: 10 NOV 2011
- Article first published online: 18 JUL 2011
- Manuscript Accepted: 4 JUN 2011
- Manuscript Revised: 3 JUN 2011
- Manuscript Received: 25 APR 2011
- cognitive behavioral therapy;
- panic disorder;
- irritable bowel syndrome
Background: High comorbidity between panic disorder with/without agoraphobia (PD/A) and irritable bowel syndrome (IBS) has been identified in the literature. These findings have resulted in the recent development of neurobiological models to explain their overlapping symptoms and related origins. This study was a preliminary investigation of the influence of cognitive behavioral therapy (CBT) for PD/A on PD/A patients with and without comorbid IBS. Methods: All patients completed a thorough intake assessment, brief waitlist period, and a 12-week CBT group for PD/A. Results: The results demonstrated significant reductions in the symptoms of anxiety, depression, and overall impairment in both patient groups (ts>2.3; Ps<.05). In addition, PD/A patients with comorbid IBS also experienced reductions in the disability and distress associated with their gastrointestinal symptoms of IBS (ts>1.9; Ps<.07). Conclusions: Although additional research still is needed, these preliminary findings suggest that CBT for PD/A can be used to simultaneously treat comorbid symptoms of PD/A and IBS. Implications for the neurobiological models for these comorbid conditions were discussed. Depression and Anxiety, 2011. © 2011 Wiley Periodicals, Inc.